Health & Biotech
Health & Biotech
ASX Health Stocks: Canada says yes to Telix, while EBR keeps market in suspense over pending announcement
Health & Biotech
Incannex jumps another hurdle to advance to Phase 2 clinical trials of its anti-inflammatory drug
Health & Biotech
Clinical Trials 101: The critical review process and getting drugs to market
Health & Biotech
ASX Biotech Stocks: This brain training app could catch dementia early and Brainchip nabs more patents
Health & Biotech
Exopharm identifies two new lead programs as exosomes gain prominence in gene therapy
Health & Biotech
Weed Week: US looks to decriminalise cannabis and Victoria Greens say legal weed could mean $1.21bn in revenue
Health & Biotech
ASX Health Stocks: Cynata races ahead after getting green light for diabetic foot ulcer clinical trial
Health & Biotech
Clinical Trials 101: How to know your placebos from blinded studies
Health & Biotech
Wellnex: This is the summer when Australia will discover the real cannabidiol (CBD) opportunity
Health & Biotech
This transport company is saving time and money with Skin Elements all-natural disinfectant
Health & Biotech
Wellnex says it is ready to get ‘product on Aussie shelves by Xmas’ after deal opens giant new med-cannabis market
Health & Biotech
EZZ Life Science Holdings takes big leaps for future global growth
Health & Biotech
Another breakthrough for Zantrene as Race Oncology significantly expands its addressable market
Health & Biotech
Creso ready to capitalise on potential US reclassification of cannabis
Health & Biotech
Prescient Therapeutics at forefront of overcoming challenges with game-changing CAR-T cell cancer therapies
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.